Workflow
Nutex Health (NUTX)
icon
搜索文档
Investors who lost money on Nutex Health Inc. (NUTX) should contact The Gross Law Firm about pending Class Action - NUTX
Prnewswire· 2025-09-22 12:45
Accessibility StatementSkip Navigation NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/nutex-health-inc-loss-submission-form/?id=1 ...
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER
Prnewswire· 2025-09-22 10:30
Accessibility StatementSkip Navigation HOUSTON, Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Wesley Bamburg as the Company's Chief Operating Officer, effective October 13, 2025. The Population Health Manageme ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
Globenewswire· 2025-09-21 15:25
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Globenewswire· 2025-09-21 12:35
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE NEWSW ...
Investors in Nutex Health Inc. Should Contact Levi & Korsinsky Before October 21, 2025 to Discuss Your Rights – NUTX
Globenewswire· 2025-09-19 20:36
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex- ...
Faruqi & Faruqi Reminds Nutex Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2025 - NUTX
Prnewswire· 2025-09-18 22:23
Accessibility StatementSkip Navigation NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruq ...
Shareholders that lost money on Nutex Health Inc. (NUTX) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
Globenewswire· 2025-09-18 20:36
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/nutex-health-inc-loss-submission-form/?id=167848&from=3 CLASS PERIOD: August 8, ...
ROSEN, A LEADING GLOBAL LAW FIRM, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
Globenewswire· 2025-09-18 19:50
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2025 in Nutex Health Inc. Lawsuit - NUTX
Prnewswire· 2025-09-18 12:45
NEW YORK , Sept. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). ...
Nutex Health Inc. (NASDAQ: NUTX) Quarterly Earnings and Financial Health Overview
Financial Modeling Prep· 2025-09-18 09:00
Nutex Health Inc. (NASDAQ:NUTX) is set to release its quarterly earnings with an anticipated EPS of -$5.43 and projected revenue of $210.89 million.The company is currently facing a class-action lawsuit over deceptive billing practices, potentially impacting its financial outlook.Despite legal challenges, NUTX's has a price-to-sales ratio of 0.80 suggest it may be undervalued.Nutex Health Inc. (NASDAQ:NUTX), a prominent healthcare company that operates micro-hospitals and healthcare facilities, is gearing u ...